Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/25/2012EP2124935B1 Antibacterial combination and its use
04/25/2012EP2101772B1 Intermediate duration neuromuscular blocking agents and antagonists thereof
04/25/2012EP2089356B1 Salt of aliskiren with orotic acid
04/25/2012EP2084147B1 Heterocyclic fxr binding compounds
04/25/2012EP2066656B1 5-substituted quinazolinone derivatives as antitumor agents
04/25/2012EP2043658B1 Antiviral phosphinate compounds
04/25/2012EP2020234B1 Synergic combination of pinaverium bromide and dimethicone or simethicone
04/25/2012EP2013207B1 Imidazo[4,5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
04/25/2012EP2005962B1 Therapeutic agent for inflammatory bowel disease
04/25/2012EP1984333B1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
04/25/2012EP1968575B1 Immunomodulatory pharmaceutical composition containing a combination of three coumarinolignoids
04/25/2012EP1937249B1 Use of at least one 2-alkyl furan, as depigmenting or lightening active principle
04/25/2012EP1888578B9 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo [4,5-c] quinolinyl)-phenyl]propionitrile as lipid kinase inhibitor
04/25/2012EP1885684B9 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor
04/25/2012EP1881834B1 Pteridines useful as hcv inhibitors and methods for the preparation thereof
04/25/2012EP1879656B1 Pharmaceutical composition comprising an antitumoral agent and an active agent selected especially among carveol, thymol and carvacrol
04/25/2012EP1848442B1 2-methylene-19-nor-(20s-24epi)-1alpha,25-dihydroxyvitamine-d2
04/25/2012EP1846363B1 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
04/25/2012EP1828137B1 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
04/25/2012EP1804797B1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
04/25/2012EP1773310B9 Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof
04/25/2012EP1745024B1 1-aryl-4-substituted isoquinolines
04/25/2012EP1732536B1 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
04/25/2012EP1720536B1 Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
04/25/2012EP1719774B1 Therapeutic agent for diabetic macular edema
04/25/2012EP1719768B1 Novel benzothiazepine and benzothiepine compounds
04/25/2012EP1658079B1 Multivitamin syrup for children or young adults
04/25/2012EP1650205B1 Cyclohexanecarboxylic acid compound
04/25/2012EP1638505B1 Amphiphilic pyridinium compounds, method of making and use thereof
04/25/2012EP1601767B1 USE OF siRNA TO SUPPRESS EXPRESSION OF EIF-5A1 IN THE TREATMENT OF GLAUCOMA
04/25/2012EP1570847B1 Phosphodiesterase 10a inhibitors for use in the treatment of parkinson's disease, huntington's disease and schizophrenia
04/25/2012EP1503748B1 2,2'-Dithio-bis(ethanesulfonate) for use in inhibiting paclitaxel-induced abnormal thermoesthesia
04/25/2012EP1482933B1 Potent, simplified derivatives of immunosuppressive agents
04/25/2012EP1450859B1 Methods and compositions for the diagnosis of asthma
04/25/2012EP1441785B1 Improved method for generating an aerosol
04/25/2012EP1432993B1 In vitro evaluation method for priocidal (anti-prion) treatments
04/25/2012EP1427810B9 Method and quantification assay for determining c-kit/scf/pakt status
04/25/2012EP1416970B1 Conjugate
04/25/2012EP1383490B1 Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases
04/25/2012EP1357912B1 Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration
04/25/2012EP1356277B1 Method for altering cell fate
04/25/2012EP1014953B1 Formulations for hydrophobic pharmaceutical agents
04/25/2012CN202198868U 治疗心经组织疾病的中药浆及包装 Treatment of cardiovascular medicine through tissue disease pulp and packaging
04/25/2012CN202198839U 一种中药治疗脾经组织疾病的装置 A traditional Chinese medicine treatment of spleen tissue disease means
04/25/2012CN1953762B Gst活化的抗癌化合物在制备改善铂类化合物的抗癌副作用的药物中的用途 Gst-activated anticancer compound in the preparation of the platinum compounds to improve the side effect of anticancer drugs in use
04/25/2012CN1929817B 包含特定的p物质拮抗剂的微乳制剂 Contains a specific substance p antagonists microemulsion
04/25/2012CN1891298B 用于胃肠外、尤其是血管内药物释放的药物贮库 For parenteral, in particular intravascular drug reservoir of drug release
04/25/2012CN1863794B 作为血管生成抑制剂的喹唑啉衍生物 As angiogenesis inhibitors quinazoline derivative
04/25/2012CN1788018B Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS 06 of pseudomonas aeruginosa
04/25/2012CN1537014B HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases
04/25/2012CN102428179A 用于增强t细胞功能的方法 Methods for enhancing the t-cell function
04/25/2012CN102428087A 用作激酶抑制剂的咪唑并吡嗪类化合物 Useful as kinase inhibitors imidazopyrazine compounds
04/25/2012CN102428086A Cdk抑制剂的盐类 Cdk inhibitors salts
04/25/2012CN102428085A 作为激酶抑制剂的嘧啶取代的嘌呤化合物 As kinase inhibitors substituted purine pyrimidine compounds
04/25/2012CN102428084A 化合物 Compound
04/25/2012CN102428083A 色原烯-2-酮衍生物及其作为单胺神经递质再摄取抑制剂的用途 Color-2-one derivatives and original as monoamine neurotransmitter reuptake inhibitor use
04/25/2012CN102428080A 神经营养因子活性参与的疾病的治疗或预防剂 Neurotrophic agent for treating or preventing diseases associated with the activity of Factor
04/25/2012CN102428079A Imidazolidine-2,4-dione derivatives and use thereof as a medicament
04/25/2012CN102428078A 神经保护、降胆固醇以及抗癫痫的化合物 Neuroprotection, cholesterol and antiepileptic compounds
04/25/2012CN102428074A α-(N-苯磺酰氨基)环烷基衍生物 α- (N- phenyl-sulfonyl-amino) cycloalkyl derivatives
04/25/2012CN102428073A 咪唑烷-2,4-二酮衍生物及其作为癌症药物的用途 Imidazolidine-2,4-dione derivatives and their use as a medicament for cancer
04/25/2012CN102428071A Substituted phenyllureas and phenylamides as vanilloid receptor ligands
04/25/2012CN102428069A 丙烯酰胺化合物及其用途 Acrylamide compounds and use thereof
04/25/2012CN102427853A Protease Inhibitors
04/25/2012CN102427828A 含具有信号肽的细菌毒素作为载体的半抗原-载体缀合物和它们在免疫原性组合物中的用途 As a carrier-hapten having a signal peptide-containing bacterial toxin - the carrier conjugates and their use in the immunogenic compositions
04/25/2012CN102427820A 用于控制外寄生虫的方法和组合物 Method for controlling ectoparasites and compositions
04/25/2012CN102427819A A3 adenosine receptor agonists for the reduction of intraocular pressure
04/25/2012CN102427818A 新用途 New uses
04/25/2012CN102427817A 起因于gne蛋白质功能降低的疾病的治疗用药物、食品组合物、食品添加剂 Due to the decrease in protein function gne treatment of diseases with drugs, food compositions, food additives
04/25/2012CN102427816A Pharmaceutical composition for treatment or prevention of ophthalmic diseases
04/25/2012CN102427815A 使用氟喹诺酮类治疗肺部细菌感染的方法 The use of fluoroquinolones in the treatment of pulmonary bacterial infection method
04/25/2012CN102427814A 激酶蛋白结合抑制剂 Kinase protein binding inhibitors
04/25/2012CN102427813A Novel anti-inflammatory agents
04/25/2012CN102427812A Use of PDE7 inhibitors for the treatment of movement disorders
04/25/2012CN102427811A 适于局部治疗皮肤和指(趾)甲真菌感染的组合物 Suitable for topical treatment of skin and finger (toe) A fungal infection of the composition
04/25/2012CN102427810A 作为trpm8拮抗剂的氨磺酰基苯甲酸衍生物 As trpm8 antagonists sulfamoyl benzoic acid derivative
04/25/2012CN102427809A Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
04/25/2012CN102427808A 基于作为细胞因子活性的活化剂或抑制剂的硫酸化透明质酸的新的用于局部应用的药剂 New medicament for topical application based on the activity of cytokines as activators or inhibitors of the sulfated hyaluronic acid
04/25/2012CN102427807A Anti-obesity agent comprising compound containing benzotropolone ring
04/25/2012CN102427806A Transdermal pharmaceutical preparation and administration of tirofiban
04/25/2012CN102427805A 固体医药组合物及其制造方法 The solid pharmaceutical composition and a method of manufacturing
04/25/2012CN102427804A 降低胆固醇水平的脂质体 Lower cholesterol levels in liposomes
04/25/2012CN102427802A 使用磺胺嘧啶银和壳聚糖制备的药用乳膏以及其制备方法 The use of silver sulfadiazine and chitosan medicinal creams and methods for their preparation
04/25/2012CN102427801A 使用硫酸新霉素b乳膏和壳聚糖制备的药用乳膏以及其制备方法 Use of neomycin sulfate and chitosan prepared b cream pharmaceutical creams and their preparation
04/25/2012CN102427797A Apigenin-containing composition
04/25/2012CN102427795A 含有聚胍*化合物的口腔组合物及其制备和使用方法 * Poly guanidine compound and preparation of oral compositions and methods of use contain
04/25/2012CN102427728A 用硫代秋水仙碱衍生物进行联合治疗 Combination therapy with colchicine derivative thiosulfate
04/25/2012CN102427727A Treatment of neurodegeneration and neuroinflammation
04/25/2012CN102427726A 丙型肝炎的稠环抑制剂 Hepatitis C inhibitors fused ring
04/25/2012CN102424699A 一种新灰毡毛忍冬皂苷及其制备方法和用途 A new macranthoides saponins and its preparation and use
04/25/2012CN102424698A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
04/25/2012CN102424696A Shikonin amino deoxy glycosides and application thereof in preparation of antitumor medicines
04/25/2012CN102424689A 甲磺酸左旋尤利沙星晶体及其制备方法和用途 L You Lisha mesylate Star crystal and preparation method and uses
04/25/2012CN102424688A 甲磺酸左旋尤利沙星晶体及其制备方法和用途 L You Lisha mesylate Star crystal and preparation method and uses
04/25/2012CN102424683A 一种藤黄酸氨基醇酯类化合物、其制备方法及医药用途 One kind of Garcinia acid amino alcohol esters, their preparation and pharmaceutical use
04/25/2012CN102424681A Acyl-tetrahydro-beta-carboline compound as well as derivatives, application and preparation method thereof
04/25/2012CN102424680A 病毒聚合酶抑制剂 Viral polymerase inhibitors
04/25/2012CN102424668A 氮杂肽衍生物 Aza-peptide derivatives
04/25/2012CN102424663A Atorvastatin amino acid and preparation method thereof
04/25/2012CN102424657A 用于癌症治疗的新型三氮烯化合物 The new triazene compounds for cancer treatment